These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8005733)

  • 21. [Study of estrogen and progesterone receptors in endometrial carcinoma].
    Chen Y; Peng Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):98-100. PubMed ID: 12501628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis.
    Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Thorpe SM
    Int J Gynecol Pathol; 1993 Jul; 12(3):246-52. PubMed ID: 7688353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas.
    Halperin R; Zehavi S; Dar P; Habler L; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 2001; 22(4):292-6. PubMed ID: 11695812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.
    Lacombe MJ; Delarue JC; Mouriesse H; Contesso G; Friedman S; Sancho-Garnier H; Travagli JP; May-Levin F
    Gynecol Oncol; 1989 Feb; 32(2):174-9. PubMed ID: 2910778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
    Nadji M; Gomez-Fernandez C; Ganjei-Azar P; Morales AR
    Am J Clin Pathol; 2005 Jan; 123(1):21-7. PubMed ID: 15762276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?
    Benraad TJ; Friberg LG; Koenders AJ; Kullander S
    Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma].
    Shen K; Yueng W; Ngan H
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):284-8, 317-8. PubMed ID: 7956553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor status.
    Horbelt DV; Freedman RS; Roberts DK; Walker NJ; Edwards CL; Jones LA
    Gynecol Oncol; 1984 Jun; 18(2):150-6. PubMed ID: 6735260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study.
    Kelley TW; Borden EC; Goldblum JR
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):338-41. PubMed ID: 15536333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival.
    Chambers JT; Carcangiu ML; Voynick IM; Schwartz PE
    Am J Clin Pathol; 1990 Sep; 94(3):255-60. PubMed ID: 1697730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hydrophobic DNA adducts in relationship to estrogen and progesterone receptors content in human uterine cancer].
    Postawski K; Olech-Fudali E; Korobowicz E; Jakowicki JA; Keith G; Baranowski W
    Ginekol Pol; 2001 Sep; 72(9):709-16. PubMed ID: 11757482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer.
    De Negri F; Campani D; Sarnelli R; Martini L; Gigliotti A; Bonacci R; Fabbri R; Squartini F; Pinchera A; Giani C
    Am J Clin Pathol; 1991 Jul; 96(1):53-8. PubMed ID: 2069136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma.
    Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S
    Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
    Itoh E
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
    Samsonova EA; Maksimova NA; Urmancheeva AF; Pozharisskiĭ KM
    Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation.
    Brustein S; Fruchter R; Greene GL; Pertschuk LP
    Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs.
    Sartin EA; Barnes S; Kwapien RP; Wolfe LG
    Am J Vet Res; 1992 Nov; 53(11):2196-200. PubMed ID: 1466519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serous papillary adenocarcinoma of the endometrium. Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry.
    Sasano H; Comerford J; Wilkinson DS; Schwartz A; Garrett CT
    Cancer; 1990 Apr; 65(7):1545-51. PubMed ID: 1690076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.